欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Histone Methyltransferase

Histone Methyltransferase

货号 产品名 CAS号 信息
CSN13507 Menin-MLL inhibitor MI-2 1271738-62-5 MI-2 can inhibits menin-MLL interaction with IC50 of 446 ± 28 nM.
CSN13635 GSK126 1346574-57-9 GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM, > 1000-fold selective for EZH2 over 20 other human methyltransferases.
CSN13673 EPZ004777 1338466-77-5 EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 0.4 nM in a cell-free assay and demonstrates > 1,200-fold selectivity for DOT1L over all other tested PMTs.
CSN13684 EPZ004777 HCl 1380316-03-9 EPZ004777 HCl is a potent, selective DOT1L inhibitor with an IC50 of 0.4 nM in a cell-free assay.
CSN13909 N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide 1403254-99-8 EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity with Ki value of 2.5±0.5 nM.
CSN12593 C-7280948 587850-67-7 C-7280948 is an inhibitor of PRMT1.
CSN18961 BRD9539 1374601-41-8 BRD9539 inhibits G9a activity with an IC50 of 6.3 μM, inhibits PRC2 activity with a similar IC50.
CSN13838 BRD4770 1374601-40-7 BRD4770 is an inhibitor of histone methyltransferase G9a with IC50 of 6.3 μM and it can induce cell senescence.
CSN22360 BIX-01338 hydrate 1228184-65-3 BIX-01338 hydrate is a histone lysine methyltransferase inhibitor.
CSN13910 Amodiaquine 2HCl Dihydrate 6398-98-7 Amodiaquine 2HCl is an inhibitor of histamine N-methyltransferase inhibitor with antimalarial and anti-inflammatory activities.
CSN12600 AMI-1 20324-87-2 AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 μM for PRMT1 via blocking peptide-substrate binding.
CSN13890 3-Deazaneplanocin A HCl 120964-45-6 3-Deazaneplanocin A HCl is a cyclopentanyl analog of 3-deazaadenosine that potently interferes with SAH, a component of the methionine cycle, which causes cellular SAH levels to increase, thus repressing the activity of S-adenosyl-l-methionine–dependent histone lysine methyltransferase activity.
<< PREV 1 2 3 4 NEXT >>
联系
我们